Introduction
============

Hydrogen sulfide (H~2~S) and nitric oxide (NO) are both gasotransmitters (Hosoki et al., [@B7]; Wang, [@B12]) that function in the cardiovascular system. Recent reports indicate that the NO and H~2~S signaling pathways interact on a variety of levels, both *in vitro* and *in vivo* (Geng et al., [@B6]; Kubo et al., [@B8],[@B9]; Yong et al., [@B17]). Exogenous NaHS, a chemical source of H~2~S, enhances NO-mediated relaxation up to 13-fold in isolated rat aorta (Hosoki et al., [@B7]). Treatment of Langendorff-perfused Sprague-Dawley rat hearts with NaHS immediately following ischemia confers cardioprotection through NOS activation (Yong et al., [@B17]). In a study on the pro-angiogenic effects of NaHS in cultured endothelial cells, Akt phosphorylation was induced after 30 min when the cells were exposed to 10--200 μM NaHS (Cai et al., [@B1]). However, this study measured NO metabolites (nitrite) instead of NO directly, and reported that there was no increase in NO metabolites with NaHS treatment (Cai et al., [@B1]). Therefore, it is not clear whether this phosphorylation resulted in an increase in NO bioavailability. In contrast, other *in vitro* studies indicate that incubation with NaHS or H~2~S gas-bubbled buffer decreases eNOS activity in aortic rings (Geng et al., [@B6]; Kubo et al., [@B9]), cell culture (Geng et al., [@B6]), and recombinant eNOS (Kubo et al., [@B8]), as well as the NO metabolites nitrite and nitrate (Geng et al., [@B6]). However, in these studies NaHS incubation occurred 1--6 h before measurement of eNOS activity or NO metabolites. Since H~2~S is volatile and oxidizes rapidly in the presence of oxygen and free divalent metals (Tapley et al., [@B11]), key signaling events mediated by H~2~S may have occurred before the activity measurement was performed. There also exists direct cross-talk between NO and H~2~S, and much work has been done investigating their interaction (Whiteman and Moore, [@B14]). There is speculation that an inert, nitrosothiol-like intermediate forms from the reaction of the two gases, which may serve as a biological sink or storage source of NO (Whiteman et al., [@B13]), and there is also evidence that the interaction of the two gases may lead to formation of nitroxyl (HNO), at least in the heart (Yong et al., [@B16]).

In the present study we investigated the ability of H~2~S, administered as the chemical source Na~2~S, to acutely modulate NO bioavailability in a cultured endothelial cell system and direct measurement of NO, with a specific focus on the potential mechanism of action through Akt.

Materials and Methods
=====================

Chemicals
---------

Endothelial cell growth supplement was purchased from Upstate (Temecula, CA, USA). All other chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) and were of the highest quality available, unless otherwise noted.

BAEC culture
------------

Bovine arterial endothelial cells (BAECs) were cultured in DMEM (1.0 g L glucose) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and endothelial cell growth supplement (5 mg L). Culture flasks were maintained in a 37°C incubator at 5.0% CO~2~. Adherent endothelial cells were grown in six-well plates for EPR measurements and in 100 mm dishes for protein expression measurements.

H~2~S exposure
--------------

Sodium sulfide (Na~2~S), an H~2~S donor, was made into a saturated stock solution in distilled water and maintained at 4°C. At this temperature, the concentration of a saturated solution of Na~2~S is 1.72 M. From this stock, Na~2~S dilutions were made in Krebs buffer, of which 1.0 mL was added per well of a six-well plate, and 3.0 mL was added per 100 mm Petri dish. In aqueous solution, hydrogen sulfide exists in equilibrium as H~2~S, HS^−^, and S^2−^. Therefore, the term "H~2~S" used throughout this manuscript refers these chemical species in aqueous solution from the addition of Na~2~S.

Akt blockade
------------

The Akt inhibitor Triciribine was used to prevent the phosphorylation of eNOS (Dieterle et al., [@B4]). Triciribine (5.0 μmol L) was added in Krebs buffer 30 min before experiments. Cells were washed with phosphate-buffered saline (PBS) before and after addition of Triciribine.

EPR detection of NO
-------------------

Spin-trapping measurements of NO were performed using a Bruker E-scan spectrometer (BrukerBioSpin Corporation, Billerica, MA, USA) with the iron spin trapping complex *N*-methyl-[d]{.smallcaps}-glucamine dithiocarbamate (Fe--MGD) (Cardounel and Zweier, [@B3]; Cardounel et al., [@B2]). For measurements of NO produced by BAECs, cells were cultured as described above and spin trapping was performed on cells grown in six-well plates (1 × 10^6^ cells well). In these studies, cells attached to the substratum were utilized since scraping or enzymatic removal leads to injury and membrane damage with impaired NO generation. The medium from each well was removed and the cells were washed with PBS (without CaCl~2~ or MgCl~2~). Cells in six-well plates were treated individually so that all six wells received the same treatment (i.e., addition of Krebs buffer or Na~2~S in Krebs buffer) for the various experiments. Next, 0.15 ml of Krebs buffer containing the NO spin trap FE--MGD (0.5 mmol L Fe^2+^, 5.0 mmol L MGD), and calcium ionophore (A23187, 1 μmol L) was added to each well and the plates were incubated at 37°C under a humidified environment containing 5% CO~2~/95% O~2~ for 20 min (Cardounel and Zweier, [@B3]; Cardounel et al., [@B2]). Following incubation, the medium from two wells was removed and pooled as one 0.3 ml sample, frozen in liquid nitrogen and stored at −80°C. This yielded three samples per plate. The frozen NO spin-trap samples are stable, and were later individually thawed, after which trapped NO in the supernatants was quantified using EPR. Spectra were obtained using the following parameters: 20 mW microwave power, 3.16 G modulation amplitude, and 100 kHz modulation frequency.

Protein expression
------------------

Six 100 mm dishes were set up with two control treatments (no Na~2~S addition), and the cells in four plates were exposed to 150 μM Na~2~S. Two of these plates were sampled 15 min later, and two were sampled 30 min later. To sample each plate, BAECs from the 100 mm dishes were scraped and suspended in 300 μl radioimmunoprecipitation assay (RIPA) buffer with Halt protease inhibitor cocktail (Thermo Fisher Scientific, Rockford, IL, USA), placed on ice, and sonicated to lyse the cells and suspend the protein. The suspension was centrifuged at 12000 × *g* for 20 min at 4°C and the supernatant removed, frozen in liquid nitrogen, and stored at −80°C. Western blotting was performed using commercially available polyclonal antibodies for eNOS and Ser 1177 eNOS (BD Biosciences, San Jose, CA, USA), monoclonal β-actin (Cell Signaling Technology, Danvers, MA, USA), and secondary antibody conjugated to alkaline phosphatase (Sigma-Aldrich St. Louis, MO, USA). Protein was separated using SDS-PAGE and transferred onto PVDF membrane (Immobilon P, Millipore, Billerica, MA, USA). Using the Snap-ID system (Millipore, Billerica, MA, USA) membranes were blocked in 0.005% non-fat milk in phosphate-buffered saline with 0.05% Tween-20 (PBST). Primary antibodies were diluted 1:333 in PBST and secondary antibody diluted 1:3,333 in blocking solution. Chemiluminescent substrate (DuoLux, Vector Laboratories, Burlingame, CA, USA) was used to generate a chemiluminescent signal, captured with a digital imager (GeneSnap, Syngene, Frederick, MD, USA). Protein from each 100 mm dish of cells (*N* = 2 dishes per treatment) was run on three separate blots, for a total of six independent measurements per treatment group. Blot images were analyzed using commercial software (Quantity One, BioRad, Hercules, CA, USA).

Statistics
----------

All data were analyzed using one-way ANOVA with Dunnett's *post hoc* test for significant differences from a control, with alpha ≤0.05 considered significant (Prism 5.0, Graph Pad Software, La Jolla, CA, USA).

Results
=======

Initial experiments were conducted to establish the time course of H~2~S effects on endothelial NO production. BAECs were exposed to a chemical source of H~2~S, Na~2~S (100 μM) for 5, 30, 60, 90, 120 and 240 min (Figure [1](#F1){ref-type="fig"}A). At each time point, endothelial-derived NO production was measured using EPR. Results demonstrated an 87% increase in mean NO production at 30 min post H~2~S treatment (ANOVA, *p* \< 0.001). This effect was not observed at later time points, suggesting a transient activation of eNOS. *Post hoc* statistical testing also revealed that levels of NO were significantly lower than control at the 90 and 240 min time points, albeit a small difference in magnitude compared to the significant increase observed at 30 min. Subsequent experiments, in which NO production was measured 30 min after the addition of 5--600 μM Na~2~S, were performed to establish the dose--response for the H~2~S effects (Figure [1](#F1){ref-type="fig"}B). Results demonstrated a 39--62% increase in mean NO production at Na~2~S concentrations between 40--150 μM (ANOVA, *p* \< 0.001).

![**The effect of H~2~S on NO production by BAECs**. NO production was measured using EPR spectroscopy. NO values (*y*-axis) are presented in arbitrary units and have been normalized to control. Time **(A)** or Na~2~S treatment concentration range **(B)** are shown on the *x*-axis. Data are shown as mean ± SE. Statistical analysis was performed using a one-way ANOVA (ANOVA *p*-value is in center of figure) with Dunnett's *post hoc* test. Numbers inside circles denote the *N* for each column. An asterisk denotes values significantly different from control by *post hoc* test. \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001.](fphys-02-00104-g001){#F1}

The transient nature of the H~2~S effects on endothelial NO production suggested a change in eNOS phosphorylation status. Therefore, western blotting was used to determine the phosphorylation state of eNOS after addition of H~2~S at 15 and 30 min. Total eNOS expression was unchanged for all treatments (Figure [2](#F2){ref-type="fig"}A, ANOVA, *p* = 0.831), but after 30 min of incubation in the presence of 150 μM Na~2~S, eNOS phosphorylation at Ser 1177 increased by 100% compared to control (Figure [2](#F2){ref-type="fig"}B, ANOVA *p* \< 0.001). Furthermore, the ratio of phosphorylated Ser 1177 eNOS to total eNOS increased by 139% after 30 min compared to control (Figure [2](#F2){ref-type="fig"}C--D, ANOVA *p* = 0.0033). To determine whether increased Ser-1177 phosphorylation was responsible for the augmented NO production, BAECs were pretreated for 30 min with the Akt inhibitor Triciribine (5 μM), after which the cells were exposed to 150 μM Na~2~S. Triciribine prevented both the increase in eNOS ser1177 phosphorylation as well as the augmentation of endothelial NO production observed with H~2~S treatment (Figure [3](#F3){ref-type="fig"}A,B, ANOVA *p* \< 0.01). These results clearly indicate that H~2~S released from Na~2~S increases endothelial NO production through Akt activation and subsequent increased phosphorylation of eNOS at Ser 1177.

![**The effect of H~2~S on eNOS phosphorylation. Protein expression (*y*-axis, normalized to β-actin) was measured from BAECs untreated (Ctrl), or exposed to 15 or 30 min of 150 μM Na~2~S (*x*-axis)**. Densiometric analysis values have been normalized to control. **(A)** Representative Western blots. **(B)** Total eNOS expression **(C)** eNOS phosphorylated at Ser 1177 expression. **(D)** The ratio eNOS phosphorylated at Ser 1177 expression over total eNOS expression. Statistical analysis was performed using a one-way ANOVA (ANOVA *p*-value is in center of figure) with Dunnett's *post hoc* test. Numbers inside circles denote the *N* for each column. An asterisk denotes values significantly different from control by *post hoc* test. \*\**p* \< 0.01, \*\*\**p* \< 0.001.](fphys-02-00104-g002){#F2}

![**The effect of Akt inhibition on H~2~S-stimulated NO production**. **(A)** Western blot analysis demonstrating total, ser1177-eNOS (phospho-eNOS), and actin in the presence and absence of the AKT inhibitor Triciribine (5 μM). **(B)** NO production was measured using EPR spectroscopy. NO values (*y*-axis) are presented in arbitrary units and have been normalized to control. NO was measured from untreated (Ctrl), Triciribine treated (Ctrl + Tri.), 150 μM Na~2~S treated (150 μM H~2~S), and 150 μM Na~2~S treated with Triciribine (H~2~S + Tri). Statistical analysis was performed using a one-way ANOVA (ANOVA *p*-value is in center of figure) with Dunnett's *post hoc* test. Numbers inside circles denote the *N* for each column. An asterisk denotes values significantly different from control by *post hoc* test, \*\**p* \< 0.01.](fphys-02-00104-g003){#F3}

Discussion
==========

Although an early study showed a synergistic effect of H~2~S on NO-induced relaxation of blood vessel rings (Hosoki et al., [@B7]), later studies showed that H~2~S inhibited eNOS activity in aortic rings and cell culture, as well as in recombinant proteins (Geng et al., [@B6]; Kubo et al., [@B8],[@B9]). However, these later studies measured eNOS activity 1--6 h after H~2~S (NaHS) addition and did not directly measure the NO produced after addition of H~2~S, as we have in this study. Since H~2~S is volatile and rapidly oxidizes in the presence of oxygen and free divalent metals (Tapley et al., [@B11]), we hypothesized that H~2~S acts within minutes of its application, not hours, and therefore that an hour or longer delay between H~2~S application and measurement of eNOS activity or, in our case, NO production could fail to detect an effect. Here we demonstrate that H~2~S from Na~2~S increases NO production from endothelial cells within 30 min.

The comparatively rapid action of Na~2~S addition lead us to suspect that H~2~S was stimulating phosphorylation of eNOS at Ser 1177. We investigated by measuring total eNOS and phosphorylated eNOS protein expression. While total eNOS remained constant for all treatment groups, there was a significant increase in both phosphorylated eNOS and the ratio of phosphorylated eNOS to total eNOS after 30 min of 150 μM Na~2~S exposure. To confirm that H~2~S-induced NO production was dependent on eNOS phosphorylation, pharmacological inhibition of Akt was used to prevent phosphorylation of eNOS at Ser 1177. Inhibition of Akt prevented the increase in NO production in cells exposed to Na~2~S, but did not significantly affect NO production in control cells. Nonetheless, it should be noted that Akt alone is not the sole mechanism of phosphorylation at Ser 1177. AMPK, PKA, and CaMKII can also contribute to phosphorylation of Ser 1177 (Fleming, [@B5]). Their contribution to the increase in NO by H~2~S cannot be ruled out by this study, and therefore they remain targets of further research.

While we assume that H~2~S gas is causing this action, hydrogen sulfide exists as H~2~S, HS^−^, and S^2−^ in solution. With the extracellular ratio of H~2~S/HS^−^ being between 1:3 and 1:5 and the intracellular ratio being approximately equal (Olson and Donald, [@B10]), HS^−^ may also be causing the up-regulation. To our knowledge, there is as yet no definitive demonstration that only H~2~S and not HS^−^ is causing the observed effects of hydrogen sulfide.

The concentrations of Na~2~S used in this study may be considered supraphysiological, given the recent finding that the circulating concentration of hydrogen sulfide is probably in the nanomolar range and not in the 10 up to 300 μM range of previous reports, many of which have used methods of measurement that artificially inflated the amount of free H~2~S detected by the assay by releasing bound sulfur as well as detecting free H~2~S (Whitfield et al., [@B15]; Whiteman and Moore, [@B14]). However, the intracellular concentrations of H~2~S have yet to be quantified, and are currently not known.

The data in the present study suggest a novel mechanism of endogenous H~2~S signaling: up-regulation of NO production via Akt-dependent phosphorylation of eNOS at Ser1177, although the mechanism by which H~2~S activates Akt is unknown. While it remains to be tested *in vivo*, upstream regulation of NO production by H~2~S could represent a novel and potentially important regulatory mechanism in NO signaling, and could further implicate a dysfunction in endogenous H~2~S signaling in cardiovascular disease and other pathologies.
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